Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 101 | ETA2024 | Next issue

46th Annual Meeting of the European Thyroid Association (ETA) 2024

Poster Presentations

Clinical thyroid cancer research-3

ea0101ps3-23-01 | Clinical thyroid cancer research-3 | ETA2024

Real-life levothyroxine intake with possible restriction of absorption in thyroid cancer patients

Pfestroff Andreas , Schmidt Anne-Sophie , Bowl Wadim , Luster Markus , Eilsberger Friederike

Objective: In patients with thyroid carcinoma, optimal thyroid hormone control, often with the aim of suppressing TSH levels, remains an essential component of tumor therapy. However, there are several factors, such as the use of pantoprazole or gastrointestinal diseases, showing a negative impact on absorption of levothyroxine and resulting in higher levothyroxine doses to achieve the desired levels.Methods: We established a questionnaire with 16 variab...

ea0101ps3-23-02 | Clinical thyroid cancer research-3 | ETA2024

Thyroid nodules in children

Nefzaoui Safa , Amri Ameni , Zoghlami Imen , Chiboub Dorra , Romdhane Nadia , Hariga Ines , Mbarek Chiraz

Background: Thyroid nodules are frequently diagnosed in adults. In children, although rare, varying between 1% and 5%, they are more likely to be malignant, hence the importance of early diagnosis and rapid management. The aim of our study was to describe the features of nodular goiters in children and to plan their management.Methods: We conducted a retrospective study including children who underwent surgery for thyroid nodules from 2001 to 2020.<p...

ea0101ps3-23-03 | Clinical thyroid cancer research-3 | ETA2024

DICER1-associated thyroid tumour families

Houda Atik , Isabelle Oliver-Petit , Solange Grunenwald , Caron Philippe , Savagner Frederique

Background: Pathogenic germline DICER1 variants cause an hereditary cancer predisposition syndrome with a variety of manifestations: in addition to first described pleuropulmonary blastoma (PPB) and ovarian sex cord-stromal tumours, individuals may also develop benign (multinodular goiter MNG, cystic nephroma.) or malignant tumours as differentiated thyroid carcinoma from infancy to adolescence and early adult.Objective: To investigate the speci...

ea0101ps3-23-04 | Clinical thyroid cancer research-3 | ETA2024

Distinguishing follicular-type thyroid carcinomas from their benign counterparts, a study of 104 consecutively resected and needle-biopsied tumors

Li Hao , Wei Khoo Hau , Bundele Manish , Lee Caroline , Tan Rong , Soon Alvin

Background: Distinguishing the malignant follicular-type thyroid neoplasm (FTTN), i.e. follicular carcinoma (FTC) and follicular-variant papillary carcinoma (FVPTC), from their benign counterparts, i.e. follicular adenoma (FA) and non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP), is challenging without surgical resection. As thyroid nodules are increasingly diagnosed asymptomatically, an accurate way of confirming benignity of FTTN can redu...

ea0101ps3-23-05 | Clinical thyroid cancer research-3 | ETA2024

Clinicopathological characteristics and outcome of patients with poorly differentiated thyroid cancer-a single center experience

Antonopoulou Vasiliki , Stratigou Theodora , Zotou Maria , Baikousi Dimitra , Koukoula Chrysoula , Beka Aikaterini , Gkoufa Kyriaki , Papalou Olga , Georgiadi Sofia , Katechakis Nikolaos , Kardalas Efstratios , Argyro Vassiliadi Dimitra , Tzanela Marinella , Ntali Georgia

Background: Poorly differentiated thyroid cancer (PDTC) is a rare entity which originates from follicular epithelial cells and ranks between differentiated (DTC) and anaplastic TC (ATC).Objective: Evaluation of clinicopathological characteristics and outcome in a series of 23 PDTC patients.Methods: Retrospective analysis of histologically confirmed PDTC patients treated in the department of Endocrinology at Evangelismos Hospital fr...

ea0101ps3-23-06 | Clinical thyroid cancer research-3 | ETA2024

Overweight as a risk factor for concomitant thyroid cancer in graves’ disease patients: a retrospective study

Park Joonseon , Seong Bae Ja , Kim Jeongsoo , Kim Kwangsoon

Background: Graves’ disease (GD) is an autoimmune disorder that causes hyperparathyroidism with the presence anti-TSH receptor antibodies (TR-Ab). The incidence of concomitant thyroid cancer in GD varies, and there is no clear consensus on the risk factors. Limited studies have examined the relationship between thyroid cancer in GD and obesity. The aim of the study was to identify the risk factors for concurrent thyroid cancer in GD patients and evaluate the impact of ove...

ea0101ps3-23-07 | Clinical thyroid cancer research-3 | ETA2024

Early detection and management of hypocalcaemia after total thyroidectomy

Hasan Dewan

Background: After total thyroidectomy Hypocalcemia is the most frequent complication. Serum calcium levels are reliable only 48–72 hours postoperatively. Now a day’s measurement of iPTH as an early predictor of postoperative hypocalcemia is practiced in many centers.Objective: To share our experience for the diagnosis and treatment of post-operative transient and permanent hypoparathyroidism after total thyroidectomy and to assess the ability o...

ea0101ps3-23-08 | Clinical thyroid cancer research-3 | ETA2024

Association between diabetes mellitus and molecular profile in papillary thyroid carcinoma patients: a retrospective study

Jesus Nuno , Goncalves Mariana , Povoa Antonia , Oliveira Maria , Soares Paula , Tavares Patricia , Maximo Valdemar

Introduction and objectives: Papillary Thyroid Carcinoma (PTC) accounts for 84% of all thyroid cancers and has shown increasing incidence in recent decades. The greater availability of imaging studies and fine needle cytology partly explains this phenomenon. However, the rising incidence of advanced-stage thyroid carcinomas suggests that this trend may be partially due to a change in the biological behaviour of these tumours. In recent years, evidence has grown indicating that...

ea0101ps3-23-09 | Clinical thyroid cancer research-3 | ETA2024

Thyroid cancer associated with hashimoto thyroidits : pronostic outcomes

Mohamed Trabelsi Wejdan , Hachicha Amani , Chouchane Hamdi , Sallemi Nesrine , Boussaffa Houneida , Turki Senda

Aim: The aim of our study was to examine the association between lymphocytic thyroiditis and papillary thyroid carcinoma.Materials and methods: It was a retrospective covering patients who had total thyroidectomy on papillary carcinoma, between 2012 and 2023.Results: Our study involved 24 patients with a median age of 50.17 years [31-73], predominantly female and a sex ratio of 0.6. Preoperative fine needle aspiration was performed...